期刊文献+

炎症性肠病患者生存质量及其影响因素的调查 被引量:17

Quality of Life and Related Factors in Patients with Inflammatory Bowel Diseases
原文传递
导出
摘要 目的研究炎症性肠病(IBD)患者的生存质量(QOL)影响因素。方法应用中文IBDQ、SF-36、焦虑自评量表、抑郁自评量表、简易应对方式问卷、社会支持评定量表,对广州市4所医院的71例炎症性肠病患者的QOL进行横断面调查,通过相关分析和多元回归分析,筛选出影响IBD患者QOL的主要因素。结果 IBD患者的生存质量得分明显下降,显著低于正常对照组的生存质量,P<0.05。多元回归分析提示,对生存质量影响的因素为:抑郁、病情、焦虑、病期、年龄。结论 IBD患者的生存质量水平较低,其中年轻(<35岁)、病情重的IBD患者的生存质量较低;缓解期IBD患者主要在心理健康方面的QOL受到影响。焦虑、抑郁水平越高,患者的生存质量越低。 Objective To investigate the quality of life(QOL) in patients with inflammatory bowel diseases(IBD) and the factors related to the QOL of patients with IBD. Methods A crass-sectional survey was carried out in four hospitals in Guangzhou city, and 71 IBD patients were recruited in the study. IBDQ, SF-36, Self-rating Anxiety Scale (SAS), Self-rating Depression Scale (SDS), Simplified Coping Style Scale and Social Support Questionnaire were used in this study. Demographic data and disease-related indicators were collected. Those data of the IBD patients were compared with that of 103 normal persons. Correlation and multiple regression analysis were applied in data analysis to identify the factors which were related to the QOL of IBD patients. Results The score of QOL in IBD patients was lower than that in normal control group. The factors that impacted on the QOL of the IBD patients were seriated by multiple regression model as depression, severe IBD cases, education level, anxiety, disease relapse and age. Conclusion The QOL of IBD patients was low. The QOL of young patients aged 〈 35 with IBD was lower than that of the older patients. The QOL of severe cases was lower than those mild cases. The QOL of patients in relapse was impaired in all domains ,while the QOL of patients in remission was mainly impaired in psychological and social domains. The QOL of IBD patients with higher anxiety and/or depression level was relatively low.
出处 《中华全科医学》 2011年第1期90-92,共3页 Chinese Journal of General Practice
关键词 炎症性肠病 生存质量 心理健康 应对方式 社会支持 Quality of life Inflammatory bowel disease Mental health Coping style Social support
  • 相关文献

参考文献9

  • 1高晶,王迪.炎症性肠病治疗的研究[J].医学综述,2004,10(5):276-278. 被引量:5
  • 2陆嵘,房静远.炎症性肠病的遗传学研究进展[J].中华消化杂志,2003,23(10):620-622. 被引量:7
  • 3Dianne S, Robert T. Coping methods of patients with inflammatory bowel disease and prediction of perceived health, functional status, and well-being[ J ]. Gastroenterol Nuts, 1998,21 ( 3 ) : 112-118.
  • 4Sands BE. From symptom to diagnosis : clinical distinctions among various forms of intestinal inflammation [ J ]. Gastroenterology, 2004,126 (6) :1518-1532.
  • 5周璐,陆星华.炎症性肠病患者的健康相关生存质量[J].中华内科杂志,2004,43(5):392-394. 被引量:89
  • 6Grenth J, Torok HP, Koenig A, et al. Comparison of inflammatory bowel disease at younger and older age [ J ]. Eur J Med Res, 2004,9 (12) : 552-554.
  • 7Casellas F,Aleala MJ,Prieto L, et al. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire [ J ]. Am J Gastroenterol, 2004, 99(3) :457-461.
  • 8Hjortswang H, Jarnerot G, Curman B, et al. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis[ J ]. Eur J Gastroenterol Hepatol,2003, 15(9) :1011-1020.
  • 9Mittermaier C, Dejaco C, Waldhoer T, et al. Impact depressive mood on relapse in patients with inflammatory bowel disease:a prospective 18- month follow-up study[ J]. Psychosomatic Medicine ,2004,66( 1 ) :79- 84.

二级参考文献45

  • 1欧阳钦.我国炎性肠病研究的概况及展望[J].中华消化杂志,1993,13(6):313-314. 被引量:41
  • 2Sugimura K, Taylor KD, Lin YC, et al. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet, 2003, 72:509-518.
  • 3Judge T, Lichtenstein GR. The NOD2 gene and Crohn's disease:another triumph for molecular genetics. Gastroenterology, 2002,122 : 826-828.
  • 4Sendid B, Quinton JF, Charrier G, et al. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol, 1998, 93:1306-1310.
  • 5Subhani J, Montgomery SM, Ounder RE, et al. Concordance rates of twins and siblings in inflammatory bowel disease. Gut, 1998,42 : 40-42.
  • 6Bonen DK, Cho JH. The genetics of inflammatory bowel disease.Gastroenterology, 2003, 124: 521-536.
  • 7Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology, 2002, 122: 867-874.
  • 8Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology, 2003, 124:993-1000.
  • 9Bonen DK, Ogura Y, Nicolae DL, et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology, 2003,124: 140-146.
  • 10Hugot JP, Chamaillard M, gouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn' s disease.Nature, 2001, 411 : 599-603.

共引文献94

同被引文献141

引证文献17

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部